Showing 361-370 of 7932 results for "".
Re-introducing Ortho Dermatologics, Tremfya Approved, Obagi Acquired
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-re-introducing-ortho-dermatologics-tremfya-approved-obagi-acquired/18458/Valeant Pharmaceuticals is changing the name of its dermatology division to Ortho Dermatologics. In an exclusive interview with DermWireTV, Executive Vice President and dermatology industry veteran William Bill Humphries discusses the change. The FDA has approved Janssen Biotech's Tremfya (guselkumaWhy Your Dermatology Practice Should Be On Instagram
https://practicaldermatology.com/topics/practice-management/dermpracticeinstagram/18473/Instagram is different from most social networks. And it's growing quickly with skyrocketing mobile technology use. It's a marketing opportunity for dermatologists, especially those interested in cosmetic procedures. Learn how to use Instagram for your practice marketing and outreach in this Ekwa.coTo Be Shorr: Importance of Using Technology to Its Fullest Extent
https://practicaldermatology.com/topics/practice-management/to-be-shorr-importance-of-using-technology-to-its-fullest-extent/18605/Some of the administrative tasks that bog down a practice can be automated—and your existing vendors may have the applications and technology you need to make it happen. Be sure to investigate the services your vendors provide, many of which you already pay for, to make the most of your practice tecPearls for Injectables: From Toxins to Fillers
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/pearls-for-injectables-from-toxins-to-fillers/18628/Ava Shamban, MD shares her rationale for thinking of the face in three treatment areas for rejuvenation procedures—upper, middle, and lower. Devising strategies with injections targeted to each area will help patients achieve more natural recountouring while achieving the youthful appearance they deHow Page Load Speed Impacts SEO And User Experience for a Dermatology Website
https://practicaldermatology.com/topics/practice-management/how-page-load-speed-impacts-seo-and-user-experience-for-a-dermatology-website/18968/This Ekwa educational video offers tips for improving your SEO ranking and your website visitor experience by ensuring optimum performance. Page load speeds are an important consideration when evaluating your dermatology practice website.Levia Introduction
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/levia-introduction-/19428/Levia technology overview, product demonstration and product insights from Lerner Medical Devices team members. Levia®, from Lerner Medical, provides Personal Targeted Phototherapy® for the self-treatment of psoriasis in the privacy and convenience of a patient's home. Levia incorporates easy to usISDPA: Dr. Bhatia on JAK Inhibitors
https://practicaldermatology.com/conferences/isdpa-midwest-derm-2024/isdpa-dr-bhatia-jak-inhibitors/27064/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, talks about his presentation on JAK inhibitors at the Illinois Society of Dermatology Physician Assistants (ISDPA) Midwest Dermatology Conference 2024.SDPA: Sara Wilchowski Talks About Transitioning to Industry and Understanding How Nutraceuticals Can Help Patients
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-sara-wilchowski-talks-about-transitioning-to-industry-and-understanding-how-nutraceuticals-can-help-patients/29513/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Sara Wilchowski, DMSc, MPAS, PA-C. Wilchowski is currently a senior medical science liaison and joined a panel of MSLs to discuss the ins and outs of transitioning to industry. Following the panel, she gave a lDermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologyExploring High-Dose Neurotoxin Injections
https://practicaldermatology.com/conferences/maui-derm-2022/exploring-high-dose-neurotoxin-injections/20055/Michael H. Gold, MD shares his thoughts on the potential benefits of high-dose neurotoxin injections for some patients. He discusses his experience and the kind of results he's been able to achieve.